Estados financieros detallados de Celularity Inc. (CELU): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Celularity Inc. registró ingresos de $26.6M en el último ejercicio fiscal, con un CAGR de 5 años del 13.2%.
Márgenes de los últimos 12 meses: margen bruto 76.0%, margen operativo -230.9%, margen neto -345.4%.
Al precio actual de $1.29, CELU presenta beneficios negativos (P/E no significativo) y un ROE del 411.46%. La capitalización bursátil es de $37M.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $17.6M | $21.1M | $14.3M | $21.3M | $18.0M | $22.8M | $54.2M | $26.6M |
| Coste de Ventas | $6.6M | $6.3M | $4.9M | $9.7M | $19.7M | $16.0M | $15.0M | $6.4M |
| Beneficio Bruto | $11.0M | $14.8M | $9.3M | $11.7M | -$1.7M | $6.8M | $39.2M | $20.2M |
| I+D | $29.1M | $46.1M | $52.7M | $88.4M | $78.4M | $30.5M | $17.4M | $15.0M |
| Generales y Administrativos | $1098 | $41.8M | $31.3M | $71.3M | $66.0M | $50.6M | $58.6M | $51.3M |
| Gastos Operativos | $1098 | $279.0M | $161.3M | $120.7M | $23.9M | $199.0M | $77.6M | $81.5M |
| Beneficio Operativo | -$1098 | -$264.1M | -$151.9M | -$109.1M | -$25.6M | -$192.3M | -$38.4M | -$61.3M |
| EBITDA | -$1098 | -$71.0M | -$202.4M | -$88.1M | -$138.8M | -$183.9M | -$43.7M | -$77.7M |
| Gastos por Intereses | 0 | 0 | $2.4M | $3.2M | 0 | $3.0M | $6.3M | $6.8M |
| Beneficio Antes de Impuestos | -$1098 | -$268.0M | -$212.9M | -$100.1M | $14.2M | -$196.3M | -$57.9M | -$91.7M |
| Impuestos | 0 | -$56.1M | -$4.7M | $20000 | $13000 | $10000 | 0 | $3000 |
| Beneficio Neto | -$1098 | -$211.9M | -$208.2M | -$100.1M | $14.2M | -$196.3M | -$57.9M | -$91.8M |
| BPA | $0.00 | $-88.75 | $-113.06 | $-7.87 | $1.01 | $-11.02 | $-2.64 | $-3.59 |
| BPA Diluido | $0.00 | $-88.75 | $-113.06 | $-7.87 | $0.95 | $-11.02 | $-2.64 | $-3.59 |
| Acciones en Circulación (Diluidas) | $3.6M | $2.4M | $1.8M | $12.7M | $15.0M | $17.8M | $21.9M | $25.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 |
|---|
| Ingresos | $11.4M | $5.7M | $5.3M | $4.1M |
| Beneficio Bruto | $7.9M | $494000 | $3.3M | $8.6M |
| Beneficio Operativo | -$10.5M | -$15.9M | -$12.9M | -$22.1M |
| EBITDA | -$15.5M | -$20.7M | -$19.7M | -$21.7M |
| Beneficio Neto | -$19.8M | -$24.5M | -$23.1M | -$24.4M |
| BPA | $-0.84 | $-1.02 | $-0.88 | $-0.95 |
| BPA Diluido | $-0.84 | $-1.02 | $-0.88 | $-0.95 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $24707 | $28.1M | $54.3M | $37.2M | $14.0M | $227000 | $738000 | $6.2M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $3.9M | $3.1M | $6.5M | $5.2M | $7.0M | $12.1M | $13.6M | $4.7M |
| Inventario | $3.5M | $3.2M | $3.9M | $9.5M | $5.3M | $5.8M | $5.4M | $571000 |
| Activos Corrientes | $24707 | $36.8M | $72.2M | $59.1M | $33.5M | $19.8M | $20.6M | $12.3M |
| Inmovilizado Material | $4.0M | $66.4M | $90.1M | $90.6M | $88.7M | $78.8M | $72.4M | $66.5M |
| Fondo de Comercio | $130.6M | $127.1M | $123.3M | $123.3M | $119.7M | $7.3M | $7.3M | $7.3M |
| Activos Intangibles | $393.7M | $271.5M | $125.4M | $123.2M | $121.0M | $11.0M | $9.2M | $7.8M |
| Activos Totales | $24707 | $521.5M | $431.0M | $414.1M | $401.1M | $143.9M | $132.7M | $107.3M |
| Cuentas por Pagar | $5.3M | $18883 | $5.4M | $9.3M | $5.8M | $14.1M | $23.3M | $26.4M |
| Deuda a Corto | 0 | 0 | $3.0M | $3.1M | $37.6M | $39.2M | $6.4M | $14.0M |
| Pasivos Corrientes | $150555 | $20.6M | $26.7M | $26.2M | $62.1M | $67.3M | $53.7M | $80.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $35.9M | 0 |
| Pasivos Totales | $150555 | $383.6M | $412.3M | $314.7M | $202.2M | $102.9M | $123.8M | $145.4M |
| Reservas | -$1098 | -$355.3M | -$563.6M | -$663.7M | -$645.5M | -$841.8M | -$899.7M | -$991.5M |
| Patrimonio Neto | -$125847 | $137.9M | $18.7M | $99.4M | $198.9M | $41.0M | $8.8M | -$38.1M |
| Deuda Total | $150000 | $28.1M | $30.6M | $31.1M | $65.6M | $65.4M | $68.8M | $40.9M |
| Deuda Neta | $125293 | -$66000 | -$23.7M | -$6.1M | $51.6M | $65.2M | $68.1M | $34.7M |
| Capital Circulante | -$125848 | $16.2M | $45.5M | $32.9M | -$28.6M | -$47.5M | -$33.1M | -$68.4M |
Balance (Trimestral)
| Año | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 |
|---|
| Caja y Equivalentes | $293000 | $863000 | $120000 | $6.2M |
| Activos Totales | $128.9M | $120.3M | $114.2M | $107.3M |
| Pasivos Totales | $134.4M | $145.8M | $134.3M | $145.4M |
| Patrimonio Neto | -$5.5M | -$25.5M | -$20.1M | -$38.1M |
| Deuda Total | $69.8M | $70.2M | $66.8M | $40.9M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$13.4M | $5.9M | -$208.2M | -$100.1M | $14.2M | -$196.3M | -$57.9M | -$91.7M |
| Amortizaciones | $4.8M | 0 | $8.2M | $8.8M | $9.4M | $11.5M | $7.9M | $7.3M |
| Compensación en Acciones | $4.5M | 0 | $4.4M | $40.0M | $15.9M | $15.0M | $11.6M | $10.4M |
| Cambio en Capital Circulante | -$1.3M | $136389 | $3.6M | -$5.7M | -$15.5M | -$6.8M | $22.2M | $33.6M |
| Flujo de Caja Operativo | -$543 | -$1.1M | -$63.2M | -$110.1M | -$137.9M | -$38.7M | -$6.4M | -$13.3M |
| Inversiones (CapEx) | -$1.9M | $3 | -$27.8M | -$6.2M | -$5.2M | -$4.0M | -$161000 | 0 |
| Adquisiciones | -$29.3M | 0 | $15.0M | 0 | 0 | 0 | -$1.5M | 0 |
| Recompra de Acciones | 0 | 0 | -$256000 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$5.9M |
| Flujo de Caja Libre | -$1.9M | -$1.1M | -$91.0M | -$116.3M | -$143.1M | -$42.7M | -$6.6M | -$13.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 |
|---|
| Flujo de Caja Operativo | -$3.0M | -$998999 | -$4.2M | -$5.1M |
| Inversiones (CapEx) | 0 | -$1 | 0 | 0 |
| Flujo de Caja Libre | -$3.0M | -$999000 | -$4.2M | -$5.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.6M | $2.4M | $2.0M | $3.3M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +20.5% | -32.5% | +49.4% | -15.7% | +26.7% | +138.1% | -51.0% |
| Crecimiento Beneficio Neto (anual) | | -19296894.5% | +1.7% | +51.9% | +114.2% | -1483.1% | +70.5% | -58.6% |
| Crecimiento BPA (anual) | | | -27.4% | +93.0% | +112.9% | -1186.3% | +76.0% | -35.7% |
| Cambio en Acciones (anual) | | -33.6% | -22.8% | +591.0% | +17.7% | +18.9% | +22.9% | +16.9% |
| Crecimiento FCF (anual) | | +42.8% | -8191.5% | -27.8% | -23.1% | +70.1% | +84.6% | -102.0% |
| Margen Bruto | 62.7% | 70.1% | 65.5% | 54.8% | -9.4% | 29.7% | 72.4% | 76.0% |
| Margen Operativo | -0.0% | -1249.0% | -1064.0% | -511.2% | -142.4% | -844.4% | -70.7% | -230.9% |
| Margen EBITDA | -0.0% | -335.6% | -1417.6% | -413.0% | -772.4% | -807.8% | -80.6% | -292.5% |
| Margen Neto | -0.0% | -1001.9% | -1458.4% | -469.3% | 79.0% | -862.0% | -106.8% | -345.8% |
| Margen FCF | -10.9% | -5.2% | -637.5% | -545.1% | -796.2% | -187.7% | -12.1% | -49.9% |
| Tasa Impositiva Efectiva | -0.0% | 20.9% | 2.2% | -0.0% | 0.1% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.53 | $-0.46 | $-49.42 | $-9.14 | $-9.55 | $-2.40 | $-0.30 | $-0.52 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.23 |
| Acciones en Circulación (Básicas) | $3.6M | $2.4M | $1.8M | $12.7M | $14.0M | $17.8M | $21.9M | $25.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 411.46% |
| Rentabilidad sobre capital invertido | -151.11% |
| Rentabilidad sobre activos | -85.45% |
| Margen bruto | 76.04% |
| Margen operativo | -230.92% |
| Margen neto | -345.44% |
Salud financiera
| Deuda / Patrimonio | -1.07 |
| Ratio corriente | 0.15 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -15.22 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -320753.64 | -1.12 | -0.97 | -6.51 | 12.72 | -0.22 | -0.79 | -0.31 |
| P/VC | -2798.54 | 1.72 | 10.83 | 6.55 | 0.91 | 1.07 | 5.15 | -0.75 |
| P/V | 20.06 | 11.23 | 14.19 | 30.54 | 10.04 | 1.93 | 0.84 | 1.07 |
| Margen Bruto | 62.7% | 70.1% | 65.5% | 54.8% | -9.4% | 29.7% | 72.4% | 76.0% |
| Margen Operativo | -0.0% | -1249.0% | -1064.0% | -511.2% | -142.4% | -844.4% | -70.7% | -230.9% |
| Margen Neto | -0.0% | -1001.9% | -1458.4% | -469.3% | 79.0% | -862.0% | -106.8% | -345.8% |